114 related articles for article (PubMed ID: 30805824)
1. Cost-Sharing for Part B Chemotherapy Drugs in Medicare Advantage Plans: an Administrative Data Analysis.
Keohane LM; Finch CJ
J Gen Intern Med; 2019 Jul; 34(7):1119-1120. PubMed ID: 30805824
[No Abstract] [Full Text] [Related]
2. Average out-of-pocket health care costs for Medicare+Choice enrollees increase substantially in 2002.
Gold M; Achman L
Issue Brief (Commonw Fund); 2002 Nov; (575):1-8. PubMed ID: 12425302
[No Abstract] [Full Text] [Related]
3. Average out-of-pocket health care costs for Medicare+Choice enrollees increase 10 percent in 2003.
Gold M; Achman L
Issue Brief (Commonw Fund); 2003 Aug; (667):1-9. PubMed ID: 12911025
[No Abstract] [Full Text] [Related]
4. Medicare program; reduction in Medicare Part B premiums as additional benefits under Medicare+Choice plans. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2003 Nov; 68(229):66721-3. PubMed ID: 14649655
[TBL] [Abstract][Full Text] [Related]
5. Avoiding the Medicare Advantage/Medicaid "payment gap".
Labban AJ
J Med Assoc Ga; 2015; 104(4):40. PubMed ID: 27451584
[No Abstract] [Full Text] [Related]
6. Medicare Benefit Redesign: Enhancing Affordability for Beneficiaries While Promoting Choice and Competition.
Schoen C; Davis K; Buttorf C; Willink A
Issue Brief (Commonw Fund); 2018 Oct; 2018():1-14. PubMed ID: 30358960
[TBL] [Abstract][Full Text] [Related]
7. Implications of Proposed Medicare Reforms to Counteract High Cancer Drug Prices.
Mailankody S; Prasad V
JAMA; 2016 Jul; 316(3):271-2. PubMed ID: 27149663
[No Abstract] [Full Text] [Related]
8. The Cost of Medicare Advantage.
Frakt AB
JAMA; 2016 Jun; 315(22):2387-8. PubMed ID: 27299607
[No Abstract] [Full Text] [Related]
9. Small PMPM rate hike may spell doom for benefit-rich, no-cost Medicare risk products.
Public Sect Contract Rep; 1998 Jan; 4(1):10-2. PubMed ID: 10177372
[TBL] [Abstract][Full Text] [Related]
10. Out-of-hand spending. Medicare+Choice out-of-pocket costs on the rise.
Tieman J
Mod Healthc; 2003 Aug; 33(33):7, 14. PubMed ID: 12964475
[No Abstract] [Full Text] [Related]
11. Choices abound in the vast new world of Medicare: HMO, PPO, PSO, MSA.
Van Koevering M
Healthplan; 1998; 39(1):50-4. PubMed ID: 10176898
[No Abstract] [Full Text] [Related]
12. Medicare's risk-adjusted capitation method.
Grimaldi PL
J Health Care Finance; 2002; 28(3):105-19. PubMed ID: 12079148
[TBL] [Abstract][Full Text] [Related]
13. Do Larger Health Insurance Subsidies Benefit Patients or Producers? Evidence from Medicare Advantage.
Cabral M; Geruso M; Mahoney N
Am Econ Rev; 2018 Aug; 108(8):2048-87. PubMed ID: 30091862
[TBL] [Abstract][Full Text] [Related]
14. Making Medicare advantage a middle-class program.
Glazer J; McGuire TG
J Health Econ; 2013 Mar; 32(2):463-73. PubMed ID: 23454916
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
[TBL] [Abstract][Full Text] [Related]
16. Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions. Final rule with comment period.
Fed Regist; 2009 Jan; 74(7):1493-549. PubMed ID: 19143114
[TBL] [Abstract][Full Text] [Related]
17. Managed Medicare at the crossroads.
Parsons DW
Eff Clin Pract; 1999; 2(1):47-8. PubMed ID: 10346554
[No Abstract] [Full Text] [Related]
18. Managed care outlook. Premiums up, benefits down for M+C.
Manag Care; 2003 May; 12(5):56. PubMed ID: 12800750
[No Abstract] [Full Text] [Related]
19. Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2017; Medicare Advantage Bid Pricing Data Release; Medicare Advantage and Part D Medical Loss Ratio Data Release; Medicare Advantage Provider Network Requirements; Expansion of Medicare Diabetes Prevention Program Model; Medicare Shared Savings Program Requirements. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2016 Nov; 81(220):80170-562. PubMed ID: 27906531
[TBL] [Abstract][Full Text] [Related]
20. Voluntary disenrollment from Medicare advantage plans: valuable signals of market performance.
Mobley LR; McCormack LA; Wang J; Squire C; Kenyon A; Lynch JT; Heller A
Am J Manag Care; 2007 Dec; 13(12):677-84. PubMed ID: 18069911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
